Sinco Pharmaceutical Holdings (HKSE:06833) EV-to-FCF : 0.89 (As of May. 16, 2024)

Sinco Pharmaceutical Holdings EV-to-FCF Chart

Sinco Pharmaceutical Holdings Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-FCF		Get a 7-Day Free Trial					-52.31	4.08	10.30	15.44	0.90

Sinco Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-FCF	Get a 7-Day Free Trial														10.30	-	15.44	-	0.90

Competitive Comparison of Sinco Pharmaceutical Holdings's EV-to-FCF

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinco Pharmaceutical Holdings's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's EV-to-FCF falls into.

Sinco Pharmaceutical Holdings EV-to-FCF Calculation

Sinco Pharmaceutical Holdings's EV-to-FCF for today is calculated as:

Sinco Pharmaceutical Holdings's current Enterprise Value is HK$280 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinco Pharmaceutical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$316 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinco Pharmaceutical Holdings  (HKSE:06833) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sinco Pharmaceutical Holdings's PE Ratio for today is calculated as:

Sinco Pharmaceutical Holdings's share price for today is HK$0.237.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinco Pharmaceutical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.023.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Sinco Pharmaceutical Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinco Pharmaceutical Holdings (HKSE:06833) Business Description